Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
AtaiBeckley Stock Skyrockets As Psychedelic Rally Extends On Trump Fast‑Track Order
02:36pm, Monday, 20'th Apr 2026
ATAI surged 28.1% in premarket trading as investors piled into the sector after the administration's weekend directive. The move sparked a broad wave of buying across psychedelic‑focused companies.
Duke Energy: 100-Year Dividend Track Record — But $103B Capex Is Compressing The Credit Cushion
02:22pm, Monday, 20'th Apr 2026
Duke Energy ended FY2025 with adjusted EPS of $6.31, covering its $4.22 annual dividend at approximately 1.49x. The company has paid a quarterly cash dividend for 100 consecutive years.
Race Day Starts Before You Get to the Track: StubHub and New Era Team Up for F1's North American Season and Beyond
08:30am, Monday, 20'th Apr 2026
NEW YORK--(BUSINESS WIRE)--StubHub and New Era announce a partnership that surfaces personalized merchandise offers to fans directly within the ticket purchase experience.
Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring.
08:18am, Monday, 20'th Apr 2026
AtaiBeckley and Compass Pathways are two drugmakers developing psychedelic treatments for depression.
IYRI: Covered Call REIT ETF, Strong Distribution Yield, Short, Adequate Track-Record
11:39am, Friday, 17'th Apr 2026
Neos is an investment manager with several strong, high-growth covered call ETFs. IYRI is one such ETF, focusing on REITs. It has similar characteristics to most covered call ETFs, namely a strong dis
Financial Survey: SecureAlert (OTCMKTS:TRCK) vs. CoStar Group (NASDAQ:CSGP)
01:44am, Friday, 17'th Apr 2026
CoStar Group (NASDAQ: CSGP - Get Free Report) and SecureAlert (OTCMKTS:TRCK - Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the tw
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
07:30am, Wednesday, 15'th Apr 2026
Fast Track designation has the potential to facilitate development and accelerate FDA review of imdusiran WARMINSTER, Pa., April 15, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABU
Bunker Hill on Track for June Restart. Provides Corporate Update and Commissioning Progress
06:15am, Wednesday, 15'th Apr 2026
KELLOGG, Idaho and VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) -- Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX: BNKR | OTCQB: BHLL) is pleased to provide a c
SOUTH SAN FRANCISCO, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”) a clinical stage biopharmaceutical company focused on improving patient outcomes
KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de
In Fast-Track SWIFT Challenge, National Advertising Division Finds Verizon Wireless Pricing Disclosures Adequate
10:00am, Wednesday, 08'th Apr 2026
In a Fast-Track SWIFT challenge brought by T-Mobile US, Inc., BBB National Programs' National Advertising Division determined that Verizon Communications Inc. provided adequate disclosure of a future
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
07:00am, Tuesday, 07'th Apr 2026
WELLESLEY HILLS, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, to
Archer Aviation: Too Cheap To Ignore As Flights Are On Track
10:25pm, Sunday, 05'th Apr 2026
Archer Aviation is reiterated as a buy, with commercialization imminent and valuation at historically low levels. ACHR achieved a key FAA certification milestone, positioning it as a first mover with
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
10:03am, Thursday, 02'nd Apr 2026
The company said the FDA's Fast Track designation is intended to facilitate development and expedite regulatory review for drugs that treat serious conditions and address unmet medical needs.
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
08:00am, Thursday, 02'nd Apr 2026
FDA Fast Track designation supports accelerated development and expedites regulatory review Norovirus is responsible for an estimated 685 million global cases each year and approximately $60 billion i
